Antonio Lanzavecchia

Antonio Lanzavecchia

National Institute of Molecular Genetics, INGM, Milan, Italy
Humabs BioMed, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland

Antonio Lanzavecchia, M.D., has served as Senior Vice President and Senior Research Fellow at Vir Biotechnology since December 2017.

Dr. Lanzavecchia has been the Founding Director of the Institute for Research in Biomedicine in Bellinzona, Switzerland and the Scientific Founder of Humabs BioMed SA, a Switzerland-based company that Vir acquired in 2017.

Dr. Lanzavecchia worked for almost two decades at the Basel Institute for Immunology.

He has been a Professor at the University of Genova and at the Swiss Federal Institute of Technology, ETH Zurich and is currently a Group Leader at the National Institute of Molecular Genetics in Milan, Italy.

In his various roles, Dr. Lanzavecchia has been recognized for his contributions to the development of the field of human immunology.

He is also a member of the European Molecular Biology Organization and an International Member of the U.S. National Academy of Sciences. Dr. Lanzavecchia earned his M.D. from the University of Pavia where he specialized in pediatrics and infectious diseases.